Baird Starts Reneo Pharmaceuticals (RPHM) at Outperform

Baird analyst Brian Skorney initiates coverage on Reneo Pharmaceuticals (NASDAQ: RPHM) with a Outperform rating and a price target of $28.00.

For an analyst ratings summary and ratings history on Reneo Pharmaceuticals click here. For more ratings news on Reneo Pharmaceuticals click here.

Shares of Reneo Pharmaceuticals closed at $7.23 yesterday.

You May Also Be Interested In

• UPDATE: Cowen Starts Rigetti Computing Inc. (RGTI) at Outperform
• Morgan Stanley Assumes Gemdale Corporation (600383:CH) at Equalweight
• Morgan Stanley Assumes China Vanke Co Ltd (2202:HK) (CHVKF) at Equalweight